ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 3.92 USD 22.5% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

RSLS Price Targets Summary
ReShape Lifesciences Inc

There are no price targets for RSLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ReShape Lifesciences Inc Competitors:
Price Targets
AORT
Artivion Inc
12% Upside
BIM
Biomerieux SA
17% Upside
ATEC
Alphatec Holdings Inc
20% Upside
INMD
Inmode Ltd
18% Upside
NMTC
Neuroone Medical Technologies Corp
217% Upside
SOON
Sonova Holding AG
10% Upside
SEZI
Senzime AB (publ)
133% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
ReShape Lifesciences Inc

For the last 9 years the compound annual growth rate for ReShape Lifesciences Inc's revenue is 8%. The projected CAGR for the next 1 year is 53%.

8%
Past Growth
53%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ReShape Lifesciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
ReShape Lifesciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RSLS's stock price target?
Not Available

RSLS doesn't have any price targets made by Wall Street professionals.

What is ReShape Lifesciences Inc's Revenue forecast?
Projected CAGR
53%

For the last 9 years the compound annual growth rate for ReShape Lifesciences Inc's revenue is 8%. The projected CAGR for the next 1 year is 53%.

Back to Top